Pulsatile insulin secretion: Detection, regulation, and role in diabetes

Diabetes

Volumn 51, Issue SUPPL., 2002, Pages

  Pørksen, Niels ^a   Hollingdal, Malene ^a   Juhl, Claus ^a   Butler, Peter ^b   Veldhuis, Johannes D ^c   Schmitz, Ole ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; SOMATOSTATIN;

ADIPOSE TISSUE; CELL FUNCTION; CONFERENCE PAPER; DISEASE COURSE; HORMONAL REGULATION; HUMAN; INSULIN RELEASE; LIVER; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSCILLATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; QUANTITATIVE ANALYSIS;

EID: 0036311276     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2007.s245     Document Type: Conference Paper

References (151)

1. Oscillations in the blood sugar of fasting normal persons
2. Fluctuations in postabsorptive blood glucose in relation to insulin release
3. Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys
4. Synchronous, sustained oscillation of C-peptide and insulin in the plasma of fasting monkeys
5. Pulsatile, synchronous basal insulin and glucagon secretion in man
6. Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings
7. Comparison of insulin and glucagon pulsatile secretion between the rat and dog pancreas in-vitro
8. Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration
9. Greater in vivo than in vitro pulsatility of insulin secretion with synchronized insulin and somatostatin secretory pulses
10. Islet somatostatin - Microvascular, paracrine, and pulsatile regulation
11. Pulsatile insulin delivery: Physiology and clinical implications
12. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans
13. Altered pulsatile insulin secretion associated with endurance training
14. Rapid reduction and return of surface insulin receptors after exposure to brief pulses of insulin in perifused rat hepatocytes
15. Association between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects
16. Pulsatile insulin has greater hypoglycemic effect than continuous delivery
17. Metabolic effects of pulsatile insulin infusion in the elderly
18. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: Importance of pulse frequency
19. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients
20. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels
21. Body fat distribution and peripheral insulin sensitivity in healthy men: Role of insulin pulsatility
22. Glucose uptake and pulsatile insulin infusion: Euglycaemic clamp and [3-3H]glucose studies in healthy subjects
23. Irregular circulating insulin concentrations in type 2 diabetes mellitus: An inverse relationship between circulating free fatty acid and the disorderliness of insulin time-series in diabetic and healthy individuals
24. Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects
25. Effects of prolonged pulsatile hyperinsulinemia in humans: Enhancement of insulin sensitivity
26. Influence of nutritional state on periodicity in plasma insulin levels in monkeys
27. Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion
28. IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion rates
29. Coordinate pulsatile insulin secretion by chronic intraportally transplanted islets in the isolated perfused rat liver
30. Effects of glucose ingestion versus infusion on pulsatile insulin secretion: The incretin effect is achieved by amplification of insulin secretory burst mass
31. Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting
32. Effects of somatostatin on pulsatile insulin secretion: Elective inhibition of insulin burst mass
33. In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts
34. Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: Selective amplification of insulin secretory burst mass
35. Differential effects of glucose stimulation upon rapid pulses and ultradian oscillations of insulin secretion
36. Loss of regular oscillatory insulin secretion in islet cell antibody positive non-diabetic subjects
37. Decreased insulin and glucagon-pulse amplitude accompanying beta-cell deficiency induced by streptozocin in baboons
38. Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man
39. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes
40. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes
41. Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM
42. Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat
43. Prevention of diabetes does not completely prevent insulin secretory defects in the ZDF rat
44. Insulin secretion in insulin-resistant women with a history of gestational diabetes
45. Insulin secretory defects in polycystic ovary syndrome: Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus
46. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus
47. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus: A genetically programmed failure of the beta cell to compensate for insulin resistance
48. Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging
49. Ultradian oscillations of plasma glucose, insulin, and C-peptide in man during continuous enteral nutrition
50. Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients
51. 24-Hour glucose profiles during continuous or oscillatory insulin infusion: Demonstration of the functional significance of ultradian insulin oscillations
52. Entrainment of pulsatile insulin secretion by oscillatory glucose infusion
53. Defects in insulin secretion and action in women with a history of gestational diabetes
54. Alterations in the patterns of insulin secretion before and after diagnosis of IDDM
55. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus
56. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects
57. Oscillations in insulin secretion during constant glucose infusion in normal man: Relationship to changes in plasma glucose
58. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep
59. Circadian modulation of glucose and insulin responses to meals: Relationship to cortisol rhythm
60. Hepatic removal of insulin in normal man: Dose response to endogenous insulin secretion
61. Insulin removal in man: In vivo evidence for a receptor-mediated process
62. Glucose ingestion in dogs alters the hepatic extraction of insulin: In vivo evidence for a relationship between biologic action and extraction of insulin
63. The effect of ingestion of meat on hepatic extraction of insulin and glucagon and hepatic glucose output in conscious dogs
64. Impact of sampling technique on appraisal of pulsatile insulin secretion by deconvolution and cluster analysis
65. In vivo synchronous membrane potential oscillations in mouse pancreatic beta-cells: Lack of coordination between islets
66. Pulsatile insulin secretion into the portal vein in liver cirrhosis
67. Neural influences on oscillations in basal plasma levels of insulin in monkeys
68. Oscillatory insulin secretion after pancreas transplant
69. Analytical problems in detecting rapid insulin secretory pulses in normal humans
70. Hepatic glucose production oscillates in synchrony with the islet secretory cycle in fasting rhesus monkeys
71. In vivo pulsatility of pancreatic islet peptides
72. Oscillations of circulating plasma insulin concentrations in the rat
73. In vitro pancreatic hormonal pulses are less regular and more frequent than in vivo
74. Temporal pattern of pancreatic insulin and C-peptide secretion and of plasma glucose levels after nutritional stimulation
75. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood
76. Splanchnic and renal metabolism of insulin in human subjects: A doseresponse study
77. Measurement using tracers of steady-state turnover and metabolic clearance of insulin in dogs
78. Insulin degradation: Mechanisms, products, and significance
79. Metabolism of C-peptide in the dog: In vivo demonstration of the absence of hepatic extraction
80. Estimation of insulin secretion rates from C-peptide levels: Comparison of individual and standard kinetic parameters for C-peptide clearance
81. Islet hormone pulse intervals are dependent upon sampling frequency
82. Cluster analysis: A simple, versatile, and robust algorithm for endocrine pulse detection
83. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation
84. A recipe for randomness
85. Approximate entropy as a measure of system complexicity
86. Quantification of hormone pulsatility via an approximate entropy algorithm
87. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release
88. Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males
89. Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism
90. Patients with Cushing's disease secrete adrenocorticotropin and cortisol jointly more asynchronously than healthy subjects
91. Greater disorderliness of ACTH and cortisol release accompanies pituitary dependent Cushing's disease
92. Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals
93. The pituitary gland secretes in bursts: Appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations
94. Pulsatile insulin secretion in isolated rat islets
95. Preservation of insulin release periodicity from individual islets of obese Zucker rats
96. Isolated islets of Langerhans have slow oscillations of electrical activity
97. Oscillations in cytosolic free Ca2+, oxygen consumption, and insulin secretion in glucose-stimulated rat pancreatic islets
98. i oscillations due to bursting electrical activity in single pancreatic islets
99. Oscillations of lactate released from islets of Langerhans: Evidence for oscillatory glycolysis in beta-cells
100. 2+ in pancreatic islets correspond to pulsatile insulin release
101. 2+ oscillations in clusters of pancreatic beta-cells exposed to glucose
102. 2+ signalling and insulin release in human pancreatic beta cells
103. 2+ oscillations in pancreatic beta-cells
104. Are metabolic oscillations responsible for normal oscillatory insulin secretion?
105. A mathematical model of oscillatory insulin secretion
106. Contributions of modeling to understanding stimulus-secretion coupling in pancreatic beta-cells
107. Perturbation of insulin oscillations by nerve blockade in the in vitro canine pancreas
108. Glucose-induced amplitude regulation of pulsatile insulin secretion from individual pancreatic islets
109. Glucose induced oscillatory insulin secretion in perifused rat pancreatic islets and clonal beta-cells (HIT)
110. Pulsatile insulin release from mouse islets occurs in the absence of stimulated entry of Ca2+
111. Pulsatile insulin secretion from isolated human pancreatic islets
112. Pulsatile insulin release and electrical activity from single ob/ob mouse islets of Langerhans
113. Electrophysiology of stimulus-secretion coupling in human beta-cells
114. Islets of Langerhans generate wavelike electric activity modulated by glucose concentration
115. 2+ and insulin release in glucosestimulated pancreatic islets
116. Electrophysiological evidence for coupling between beta cells of pancreatic islets
117. 2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell
118. i oscillations in mouse pancreatic islets of Langerhans
119. Role of intrapancreatic ganglia in regulation of periodic insular secretions
120. Control of pulsatile insulin secretion in man
121. A morphologic study of intrahepatic portal-vein islet isografts
122. Reinnervation of transplanted pancreatic islets. A comparison among islets implanted into the kidney, spleen, and liver
123. Effects of galanin on the release of insulin, glucagon and somatostatin from the isolated, perfused dog pancreas
124. Neural control of insulin secretion: Interaction of norepinephrine and acetylcholine
125. Effects of acute alpha 2-blockade on insulin action and secretion in humans
126. Effects of gamma-aminobutyric acid on insulin, glucagon, and somatostatin release from perfused dog pancreas
127. Inhibition of insulin release from rat pancreatic islets by drugs that are analogues of dopamine
128. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action
129. Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations
130. Glucose entrainment of highfrequency plasma insulin oscillations in control and type 2 diabetic subjects
131. Concordant induction of rapid in vivo pulsatile insulin secretion in healthy humans by recurrent punctuated glucose infusions
132. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle
133. Fatty acids, lipotoxicity and insulin secretion
134. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion
135. Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity
136. Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo
137. Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I: Involvement of hypothalamic somatostatin
138. Hypothalmnic regulation of pulsatile thyrotopin secretion
139. Twenty-four hour rhythms of plasma catecholamines and their relation to cardiovascular parameters in healthy young men
140. Time series prediction of plasma hormone concentration: Evidence for differences in predictability of parathyroid hormone secretion between osteoporotic patients and normal controls
141. Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: Cholinergic control of GLP-1 secretion via muscarinic receptors
142. Ultradian oscillations of leptin secretion in humans
143. High frequency oscillations in circulating amylin concentrations in healthy humans
144. Short-term treatment with GLP- 1 increases pulsatile insulin secretion in type II diabetes with no effect on orderliness
145. Repaglinide amplifies insulin secretory burst mass without affecting burst frequency
146. Physiological importance of first-phase insulin release in elderly patients with diabetes
147. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance
148. Disruption of the pulsatile and entropic modes of insulin release during an unvarying glucose stimulus in elderly individuals
149. Glucose pulse induction markedly improves detection of a disrupted oscillatory insulin secretion in type 2 diabetes
150. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass
151. Beta-cell dysfunction following successful segmental pancreas transplantation